Llwytho...
Risperidone versus other antipsychotics for people with severe mental illness and co‐occurring substance misuse
BACKGROUND: Up to 75% of people with serious mental illness (SMI) such as schizophrenia and bipolar disorder have co‐occurring substance use disorders (dual diagnosis). Dual diagnosis can have an adverse effect on treatment and prognosis of SMI. OBJECTIVES: To evaluate the effects of risperidone com...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Cochrane Database Syst Rev |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
John Wiley & Sons, Ltd
2018
|
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6491096/ https://ncbi.nlm.nih.gov/pubmed/29355909 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011057.pub2 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|